Generic Name and Formulations:
Polymyxin B sulfate 10000Units, neomycin sulfate 3.5mg, hydrocortisone 10mg; per mL; otic susp.
Indications for PEDIOTIC:
Susceptible infections of external auditory canal, mastoidectomy and fenestration cavities.
Clean ear. 4 drops in ear(s) 3–4 times daily; max 10 days. May use saturated cotton wick.
Clean ear. 3 drops in ear(s) 3–4 times daily; max 10 days.
Otic fungal, tubercular, or viral infections.
Discontinue if sensitization or irritation occur. Perforated eardrum. Chronic otitis media. Reevaluate if no improvement in 1 week. Pregnancy (Cat.C). Nursing mothers.
Antibiotics + steroid.
Local reactions (eg, dermatitis), superinfection, ototoxicity, nephrotoxicity.
Susp—7.5mL (w. dropper)
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|